Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A phase Ⅰ dose-escalating trial of pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine and prednisone for aggressive non-Hodgkin lymphoma].
Shen WN, Ji DM, Xue K, Zhang QL, Lyu FF, Hong XN, Cao JN, Guo Y. Shen WN, et al. Among authors: ji dm. Zhonghua Xue Ye Xue Za Zhi. 2016 Dec 14;37(12):1044-1048. doi: 10.3760/cma.j.issn.0253-2727.2016.12.007. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 28088967 Free PMC article. Clinical Trial. Chinese.
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
Zhang B, Li N, Gao J, Zhao Y, Jiang J, Xie S, Zhang C, Zhang Q, Liu L, Wang Z, Ji D, Wu L, Ren R. Zhang B, et al. Among authors: ji d. J Exp Clin Cancer Res. 2024 Apr 16;43(1):113. doi: 10.1186/s13046-024-03033-8. J Exp Clin Cancer Res. 2024. PMID: 38622733 Free PMC article. No abstract available.
Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials.
Mao C, Ji D, Ding Y, Zhang Y, Song W, Liu L, Wu Y, Song L, Feng X, Zhang J, Cao J, Xu N. Mao C, et al. Among authors: ji d. ESMO Open. 2023 Jun;8(3):101540. doi: 10.1016/j.esmoop.2023.101540. Epub 2023 May 11. ESMO Open. 2023. PMID: 37178668 Free PMC article. Clinical Trial.
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
Zhu X, Zhao X, Peng W, Sun S, Cao J, Ji D, Liu X, Wang C, Huang M, Yu H, Guo W, Li J, Yin J. Zhu X, et al. Among authors: ji d. J Cancer Res Clin Oncol. 2015 Jan;141(1):109-18. doi: 10.1007/s00432-014-1754-8. Epub 2014 Jul 18. J Cancer Res Clin Oncol. 2015. PMID: 25035248 Clinical Trial.
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study.
Zhang J, Ji D, Cai L, Yao H, Yan M, Wang X, Shen W, Du Y, Pang H, Lai X, Zeng H, Huang J, Sun Y, Peng X, Xu J, Yang J, Yang F, Xu T, Hu X. Zhang J, et al. Among authors: ji d. Clin Cancer Res. 2022 Feb 15;28(4):618-628. doi: 10.1158/1078-0432.CCR-21-2827. Clin Cancer Res. 2022. PMID: 34844975 Clinical Trial.
1,743 results